Back to Search Start Over

24-Month Overall Survival from KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin with or without Pembrolizumab as First-Line Therapy forĀ Advanced Nonsquamous Non-Small Cell LungĀ Cancer.

Details

Language :
English
ISSN :
15560864
Volume :
14
Issue :
1
Database :
Complementary Index
Journal :
Journal of Thoracic Oncology
Publication Type :
Academic Journal
Accession number :
133664746
Full Text :
https://doi.org/10.1016/j.jtho.2018.08.004